The pathogenesis of inflammatory bowel disease centers on dysregulated immunity. It is therefore not surprising that drugs that alter host immunity can sometimes lead to the development of new-onset inflammatory bowel disease, which the authors refer to as “drug-induced secondary inflammatory bowel disease.”